We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for real-time alerts, custom portfolio, and market movers
| Share Name | Share Symbol | Market | Type |
|---|---|---|---|
| Array Technologies Inc | NASDAQ:ARRY | NASDAQ | Common Stock |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| -0.85 | -6.94% | 11.39 | 11.39 | 11.40 | 12.35 | 11.165 | 12.19 | 9,650,481 | 23:36:31 |
From May 2019 to May 2024
BOULDER, Colo., April 26, 2016 /PRNewswire/ -- Array BioPharma Inc. (Nasdaq: ARRY) will report financial results for the third quarter of fiscal 2016 and hold a conference call to discuss those results on Tuesday, May 3, 2016. Ron Squarer, Chief Executive Officer, will lead the call.
|
Date: |
Tuesday, May 3, 2016 |
|
Time: |
9:00 a.m. Eastern Time |
|
Toll-Free: |
(844) 464-3927 |
|
Toll: |
(765) 507-2598 |
|
Pass Code: |
86078064 |
|
Webcast, including Replay and Conference Call Slides: | |
About Array BioPharma
Array BioPharma Inc. is a biopharmaceutical company focused on the discovery, development and commercialization of targeted small molecule drugs to treat patients afflicted with cancer. Five registration studies are currently advancing related to three cancer drugs. These programs include binimetinib (MEK162), encorafenib (LGX818) and selumetinib (AstraZeneca). For more information on Array, please go to www.arraybiopharma.com.
|
CONTACT: |
Tricia Haugeto |
|
Array BioPharma Inc. | |
|
(303) 386-1193 | |
|
thaugeto@arraybiopharma.com |
Logo - http://photos.prnewswire.com/prnh/20121029/LA02195LOGO
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/array-biopharma-to-report-financial-results-for-the-third-quarter-of-fiscal-2016-on-may-3-2016-300257649.html
SOURCE Array BioPharma Inc.
Copyright 2016 PR Newswire
1 Year Array Technologies Chart |
1 Month Array Technologies Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
